Dec 30, 2025 • openPR.com
SOMEWHAT-BULLISH
Japan's Telemedicine and AI-Driven Healthcare Adoption Propel Growth in the Digital Health Market | Top Companies - Koninklijke Philips N.V., Medtronic plc, GE HealthCare, Siemens Healthineers, Teladoc Health
The digital health market is projected to grow at a CAGR of 20.6% during 2025-2033, reaching US$ 1,907.21 billion by 2033, driven by rapid adoption of telemedicine, wearable devices, mobile health applications, and AI-driven solutions. Japan, in particular, is witnessing significant advancements with AI-powered platforms, mobile health apps, telemedicine collaborations, and insurance reimbursements for digital therapeutics. The Asia Pacific region leads the market with a 45% share due to increasing adoption and government initiatives.
Dec 29, 2025 • MarketBeat
SOMEWHAT-BEARISH
Voya Investment Management LLC Sells 99,728,586 Shares of Teladoc Health, Inc. $TDOC
Voya Investment Management LLC significantly reduced its stake in Teladoc Health, Inc. ($TDOC) by selling 99,728,586 shares, retaining a smaller position valued at approximately $2.05 million. This divestment follows other insider selling activities, with Teladoc currently trading near $7.13 and having a "Hold" consensus rating from analysts with an average target price of $9.60. The company recently reported better-than-expected quarterly earnings but maintains a negative P/E ratio and overall negative net margin.
Dec 26, 2025 • Simply Wall Street
NEUTRAL
Will New Analyst Coverage Shape Teladoc’s Evolving Virtual Care Story for Investors (TDOC)?
Teladoc Health (TDOC) is receiving fresh institutional attention following Barclays' initiation of coverage with an "Equal Weight" rating. This new analyst scrutiny, combined with recent board changes, emphasizes the ongoing need for Teladoc to demonstrate growth and improved margins in its virtual care businesses, particularly in BetterHelp and chronic care. The article highlights that the core investment narrative for Teladoc remains reliant on its ability to scale technology and improve margins despite challenges like user churn and pricing pressure.
Dec 26, 2025 • Sahm
NEUTRAL
Will New Analyst Coverage Shape Teladoc’s Evolving Virtual Care Story for Investors (TDOC)?
Teladoc Health recently saw director J. Eric Evans announce his retirement and Barclays initiate coverage with an Equal Weight rating, bringing fresh institutional attention to the virtual care provider. Investors are reassessing Teladoc's user growth and margin profile amidst ongoing pressures in its BetterHelp business, and new analysis aims to clarify the company's long-term outlook and fair value.
Dec 26, 2025 • Simply Wall Street
NEUTRAL
Will New Analyst Coverage Shape Teladoc’s Evolving Virtual Care Story for Investors (TDOC)?
Teladoc Health (TDOC) is undergoing changes with the retirement of director J. Eric Evans and new analyst coverage from Barclays, which initiated an "Equal Weight" rating. These developments bring fresh institutional attention to the virtual care provider as investors assess its user growth and margin profile. The company's investment narrative centers on the belief that virtual care can grow into a more profitable part of healthcare, with key near-term catalysts being execution in BetterHelp and chronic care.
Dec 24, 2025 • Finviz
NEUTRAL
HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling?
This article compares telehealth stocks Hims & Hers Health (HIMS) and Teladoc Health (TDOC), evaluating their performance, valuation, and growth drivers. While both benefit from the shift to virtual care, the analysis concludes that HIMS, with its expanding specialties, diagnostic push, and international growth, offers a more compelling investment opportunity currently.